Compare INFU & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INFU | RPID |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.4M | 204.3M |
| IPO Year | 2005 | 2021 |
| Metric | INFU | RPID |
|---|---|---|
| Price | $9.55 | $4.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $15.00 | $8.00 |
| AVG Volume (30 Days) | 139.5K | ★ 160.1K |
| Earning Date | 01-01-0001 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 181.82 | 11.48 |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $143,436,000.00 | $28,051,000.00 |
| Revenue This Year | $5.29 | $19.91 |
| Revenue Next Year | $8.95 | $21.68 |
| P/E Ratio | $29.55 | ★ N/A |
| Revenue Growth | 6.36 | ★ 24.57 |
| 52 Week Low | $4.61 | $1.86 |
| 52 Week High | $11.04 | $4.94 |
| Indicator | INFU | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 66.19 | 56.07 |
| Support Level | $8.57 | $3.03 |
| Resistance Level | $9.80 | $4.46 |
| Average True Range (ATR) | 0.49 | 0.30 |
| MACD | 0.22 | 0.02 |
| Stochastic Oscillator | 100.00 | 77.05 |
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.